You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Relvar Ellipta product pack shot

Relvar Ellipta contains two medicines, fluticasone furoate and vilanterol. Relvar Ellipta is a long-acting beta2 agonist combined with an inhaled corticosteroid that is taken once daily for the treatment of asthma and COPD.

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

Relvar and Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies